Accessibility Statement Skip Navigation
  • Back to Global Sites
  • +972-77-2005042
  • Blog
  • Journalists
  • GDPR
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +972-77-2005042 from 8 AM - 11 PM IL

    • Contact
    • Contact

      +972-77-2005042
      from 8 AM - 11 PM IL

  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR

GemmaCert Pinpoints Potency and Composition of Cannabis Throughout Supply Chain

New in house technology takes guesswork out of manufacturing process and promotes accurate product labelling

GemmaCert Logo

News provided by

GemmaCert

16 Jul, 2020, 18:52 IDT

Share this article

Share toX

Share this article

Share toX

TEL AVIV, Israel, July 16, 2020 /PRNewswire/ -- GemmaCert announced today that it has added new features to its flagship analytical product and can now determine the composition and potency of cannabis throughout the entire supply chain: from the initial plant harvest up through the raw extraction that occurs right before the cannabis is turned into a useable product. GemmaCert is a life sciences company advancing solutions to determine the potency and quality of cannabis and hemp.

The company uses a nondestructive technology that employs advanced spectrometry, image analysis and machine learning. GemmaCert's leading analytical device offers a reliable and accurate breakdown of the amount of THC and CBD content during the cannabis production process, starting with the cannabis plant's dry flower buds, through their conversion into biomass and finally after the cannabis has been extracted in crude (raw) form from the biomass.

Dr. Guy Setton, GemmaCert CEO said, "The recent explosion of cannabis products on the market has left manufacturers and sellers vulnerable to lawsuits from consumers claiming that the actual cannabis content in these products is very different from what is being advertised. We are dramatically reducing the risk to manufactures of mislabeling products by taking the guesswork out of determining cannabis potency and composition. With our in-house product, manufacturers know exactly what they are breeding, growing and selling without having to invest in costly and time consuming laboratory tests."

GemmaCert also announced today the release of its new product, The GemmaCert Lite. The product is based on the company's same state-of-the-art technology platform for non-destructive cannabis potency analysis and offers many of the same features. The GemmaCert Lite, however, is intended for small cannabis businesses, craft services and growers, and sells at a lower price point of US$2,500.

GemmaCert's technology is based on research first conducted at The Hebrew University of Jerusalem by Prof. Oded Shoseyov, and the company was established by Yissum, the University's tech transfer company. Hebrew University, led by the research of Prof. Raphael Mechoulam has been uncovering the benefits of cannabis and leading the modern era of serious scientific cannabis research for over 5 decades.

About GemmaCert

GemmaCert is an Israel-based life sciences company advancing solutions to determine the potency and quality of cannabis and hemp through a non-destructive technology that uses advanced spectrometry, image analysis and machine learning.

For more information visit www.gemmacert.com

Media Requests: Hila Keinan, [email protected]

SOURCE GemmaCert

Related Links

http://www.gemmacert.com/

Modal title

Contact PR Newswire

  • +972-77-2005042
    from 8 AM - 11 PM IL

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Csezh
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italie
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+972-77-2005042
from 8 AM - 11 PM IL
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.